310 related articles for article (PubMed ID: 28124475)
1. Genome-wide two-locus interaction analysis identifies multiple epistatic SNP pairs that confer risk of prostate cancer: A cross-population study.
Shen J; Li Z; Song Z; Chen J; Shi Y
Int J Cancer; 2017 May; 140(9):2075-2084. PubMed ID: 28124475
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide two-locus epistasis scans in prostate cancer using two European populations.
Tao S; Feng J; Webster T; Jin G; Hsu FC; Chen SH; Kim ST; Wang Z; Zhang Z; Zheng SL; Isaacs WB; Xu J; Sun J
Hum Genet; 2012 Jul; 131(7):1225-34. PubMed ID: 22367438
[TBL] [Abstract][Full Text] [Related]
3. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
[TBL] [Abstract][Full Text] [Related]
4. Interactions of
Lin HY; Callan CY; Fang Z; Tung HY; Park JY
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1067-1075. PubMed ID: 30914434
[TBL] [Abstract][Full Text] [Related]
5. Interaction effect of PTEN and CDKN1B chromosomal regions on prostate cancer linkage.
Xu J; Langefeld CD; Zheng SL; Gillanders EM; Chang BL; Isaacs SD; Williams AH; Wiley KE; Dimitrov L; Meyers DA; Walsh PC; Trent JM; Isaacs WB
Hum Genet; 2004 Aug; 115(3):255-62. PubMed ID: 15185141
[TBL] [Abstract][Full Text] [Related]
6. A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer.
Nam RK; Zhang WW; Loblaw DA; Klotz LH; Trachtenberg J; Jewett MA; Stanimirovic A; Davies TO; Toi A; Venkateswaran V; Sugar L; Siminovitch KA; Narod SA
Prostate Cancer Prostatic Dis; 2008; 11(3):241-6. PubMed ID: 17876339
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.
Teerlink CC; Leongamornlert D; Dadaev T; Thomas A; Farnham J; Stephenson RA; Riska S; McDonnell SK; Schaid DJ; Catalona WJ; Zheng SL; Cooney KA; Ray AM; Zuhlke KA; Lange EM; Giles GG; Southey MC; Fitzgerald LM; Rinckleb A; Luedeke M; Maier C; Stanford JL; Ostrander EA; Kaikkonen EM; Sipeky C; Tammela T; Schleutker J; Wiley KE; Isaacs SD; Walsh PC; Isaacs WB; Xu J; Cancel-Tassin G; Cussenot O; Mandal D; Laurie C; Laurie C; ; ; Thibodeau SN; Eeles RA; Kote-Jarai Z; Cannon-Albright L
Hum Genet; 2016 Aug; 135(8):923-38. PubMed ID: 27262462
[TBL] [Abstract][Full Text] [Related]
8. Genotype distribution-based inference of collective effects in genome-wide association studies: insights to age-related macular degeneration disease mechanism.
Woo HJ; Yu C; Kumar K; Gold B; Reifman J
BMC Genomics; 2016 Aug; 17(1):695. PubMed ID: 27576376
[TBL] [Abstract][Full Text] [Related]
9. Germ-line sequence variants of PTEN do not have an important role in hereditary and non-hereditary prostate cancer susceptibility.
Xie CC; Lu L; Sun J; Zheng SL; Isaacs WB; Gronberg H; Xu J
J Hum Genet; 2011 Jul; 56(7):496-502. PubMed ID: 21633361
[TBL] [Abstract][Full Text] [Related]
10. Endometrial vezatin and its association with endometriosis risk.
Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
[TBL] [Abstract][Full Text] [Related]
11. A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.
Hoffmann TJ; Van Den Eeden SK; Sakoda LC; Jorgenson E; Habel LA; Graff RE; Passarelli MN; Cario CL; Emami NC; Chao CR; Ghai NR; Shan J; Ranatunga DK; Quesenberry CP; Aaronson D; Presti J; Wang Z; Berndt SI; Chanock SJ; McDonnell SK; French AJ; Schaid DJ; Thibodeau SN; Li Q; Freedman ML; Penney KL; Mucci LA; Haiman CA; Henderson BE; Seminara D; Kvale MN; Kwok PY; Schaefer C; Risch N; Witte JS
Cancer Discov; 2015 Aug; 5(8):878-91. PubMed ID: 26034056
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association analysis of total cholesterol and high-density lipoprotein cholesterol levels using the Framingham heart study data.
Ma L; Yang J; Runesha HB; Tanaka T; Ferrucci L; Bandinelli S; Da Y
BMC Med Genet; 2010 Apr; 11():55. PubMed ID: 20370913
[TBL] [Abstract][Full Text] [Related]
13. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.
Fitzgerald LM; Kwon EM; Koopmeiners JS; Salinas CA; Stanford JL; Ostrander EA
Clin Cancer Res; 2009 May; 15(9):3231-7. PubMed ID: 19366831
[TBL] [Abstract][Full Text] [Related]
14. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
Lindstrom S; Schumacher F; Siddiq A; Travis RC; Campa D; Berndt SI; Diver WR; Severi G; Allen N; Andriole G; Bueno-de-Mesquita B; Chanock SJ; Crawford D; Gaziano JM; Giles GG; Giovannucci E; Guo C; Haiman CA; Hayes RB; Halkjaer J; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Navarro C; Riboli E; Sacerdote C; Stampfer M; Stram DO; Thun MJ; Trichopoulos D; Virtamo J; Weinstein SJ; Yeager M; Henderson B; Ma J; Le Marchand L; Albanes D; Kraft P
PLoS One; 2011 Feb; 6(2):e17142. PubMed ID: 21390317
[TBL] [Abstract][Full Text] [Related]
15. Gene, pathway and network frameworks to identify epistatic interactions of single nucleotide polymorphisms derived from GWAS data.
Liu Y; Maxwell S; Feng T; Zhu X; Elston RC; Koyutürk M; Chance MR
BMC Syst Biol; 2012; 6 Suppl 3(Suppl 3):S15. PubMed ID: 23281810
[TBL] [Abstract][Full Text] [Related]
16. Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians.
Shan J; Al-Rumaihi K; Rabah D; Al-Bozom I; Kizhakayil D; Farhat K; Al-Said S; Kfoury H; Dsouza SP; Rowe J; Khalak HG; Jafri S; Aigha II; Chouchane L
J Transl Med; 2013 May; 11():121. PubMed ID: 23668334
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population.
Haiman CA; Han Y; Feng Y; Xia L; Hsu C; Sheng X; Pooler LC; Patel Y; Kolonel LN; Carter E; Park K; Le Marchand L; Van Den Berg D; Henderson BE; Stram DO
PLoS Genet; 2013 Mar; 9(3):e1003419. PubMed ID: 23555315
[TBL] [Abstract][Full Text] [Related]
18. Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility.
Sapkota Y; Mackey JR; Lai R; Franco-Villalobos C; Lupichuk S; Robson PJ; Kopciuk K; Cass CE; Yasui Y; Damaraju S
PLoS One; 2014; 8(6):e64896. PubMed ID: 23755158
[TBL] [Abstract][Full Text] [Related]
19. Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based study.
Camp NJ; Farnham JM; Wong J; Christensen GB; Thomas A; Cannon-Albright LA
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1290-4. PubMed ID: 19336566
[TBL] [Abstract][Full Text] [Related]
20. The identification of trans-associations between prostate cancer GWAS SNPs and RNA expression differences in tumor-adjacent stroma.
Chen X; McClelland M; Jia Z; Rahmatpanah FB; Sawyers A; Trent J; Duggan D; Mercola D
Oncotarget; 2015 Jan; 6(3):1865-73. PubMed ID: 25638161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
